Received May 11, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 93YN2 | — |
Adult dose of Havrix administered to a 16-yr old patient; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of adult product administered to child in a 16-year-old female patient who received HAV (Havrix 1440 adult) (batch number 93YN2, expiry date 03-FEB-2028) for prophylaxis. On 27-APR-2026, the patient received Havrix 1440 adult 1 ml. On 27-APR-2026, an unknown time after receiving Havrix 1440 adult, the patient experienced adult product administered to child (Verbatim: Adult dose of Havrix administered to a 16-yr old patient). The outcome of the adult product administered to child was not applicable. Additional Information: GSK Receipt Date: 28-APR-2026 A pharmacist reported that a 16-year-old patient received an adult dose of Havrix.